written on 15.04.2014
Tags:
,

Generics makers ask SCOTUS to let them proceed with Copaxone copies

TAGS: ,

Teva wants generics makers to hold off on launching their copies of multiple sclerosis drug Copaxone until the Supreme Court hears its appeal in a patent fight over the drug. And unsurprisingly, those generics companies are not that into the idea.

Latest Report